NEW YORK, August 9, 2026, 13:05 EDT — U.S. markets have ended the trading session.
- UiPath finished Friday at $15.05, up 7.5% on the day and 17.9% higher since July 31.
- The share price closed 12.3% higher than the consensus Wall Street target of $13.40.
- UiPath’s outlook points to approximately $30.5 million in net-new ARR for the second quarter at the midpoint, trailing the $49 million reported in the first quarter. This figure is an analyst calculation rather than official company guidance.
UiPath stock has surpassed broader market performance as well as analysts’ consensus price targets. Over the week, the share price ended $1.65 beyond the average target. U.S. cash markets did not open on Sunday.
The rally is significant as UiPath’s guidance continues to suggest a deceleration in sequential ARR growth. A straightforward midpoint figure could now be viewed as lacking. The company did not issue an updated outlook when it announced its August 6 earnings date.
For the week ending August 7
| Instrument | Friday move | Weekly move | Friday close |
|---|---|---|---|
| UiPath | up 7.5% | advanced 17.9% | $15.05 |
| Nasdaq Composite | added 1.3% | up 5.2% | 26,690.62 |
| S&P 500 | rose 0.6% | gained 3.6% | 7,757.64 |
Based on UiPath’s closing price of $12.76 on July 31.
Friday’s disappointing jobs data drove Treasury yields down and boosted growth stocks. UiPath outperformed the Nasdaq by about 12.7 percentage points for the week. The company still faces its own earnings challenge, despite favourable macroeconomic trends.
Short positions can intensify market swings. The most recent disclosed short interest stood at 112.93 million shares, equivalent to 28.1% of the float. This figure declined by 18.7% from the prior update, indicating that a portion of bearish bets had already been covered.
Comparison of positioning
| Measure | Latest reading | Comparison | Change |
|---|---|---|---|
| Short interest, July 15 | 112.93 million | 138.92 million prior | -18.7% |
| Short interest as percentage of float | 28.1% | — | — |
| Reported days to cover | 1.4 | — | — |
| Friday trading volume | 62.56 million | 65-day average: 60.48 million | +3.4% |
Turnover on Friday edged just above its latest average, making it less likely that the move was solely propelled by volumes. Elevated short interest may continue to fuel daily price swings.
In the first quarter, bulls saw strong results. Revenue climbed 17% to $418 million, and ARR was up 12% to $1.901 billion. Adjusted free cash flow totaled $130 million. Chief Executive Daniel Dines said agentic products were “moving from pilot to production.” UiPath, Inc.
Forecasts continue to reflect reduced quarterly ARR growth. The midpoint for the second quarter stands at $1.9315 billion, exceeding April’s figure by roughly $30.5 million. This estimate is 37.8% lower than the $49 million in net-new ARR recorded in the first quarter.
Analysts on the Street project revenue at $397.77 million, nearly matching UiPath’s guidance midpoint of $397.5 million. The consensus for adjusted earnings has held steady at $0.15 for the past three months.
September earnings challenge
| Metric | First-quarter actual | Second-quarter guide or consensus | Comparison |
|---|---|---|---|
| Revenue | $418 million | Company: $395 million-$400 million | Guide midpoint stands at $397.5 million |
| Street revenue estimate | — | $397.77 million | 0.07% above midpoint of guidance |
| ARR | $1.901 billion | $1.929 billion-$1.934 billion | Implied rise: $28 million-$33 million |
| Net-new ARR | $49 million | Calculated midpoint: $30.5 million | -37.8% from previous quarter |
| Non-GAAP operating income | $92 million | About $75 million | $17 million lower than Q1 |
| Adjusted EPS estimate | $0.15 actual | $0.15 consensus | No change in three months |
This is an estimated calculation and not an official number released by UiPath.
Analyst sentiment indicates a tougher path ahead. Out of 22 recommendations, 17 are Hold ratings. The consensus target suggests an 11% decline, with the highest target price set at $17.
Analyst ratings
| Recommendation or target | Current reading | Implied versus $15.05 |
|---|---|---|
| Buy | 3 analysts | — |
| Overweight | 1 analyst | — |
| Hold | 17 analysts | — |
| Underweight | 1 analyst | — |
| Sell | 0 analysts | — |
| Consensus | Hold | — |
| Average target | $13.40 | -11.0% |
| Median target | $13.00 | -13.6% |
| High target | $17.00 | +13.0% |
| Low target | $12.00 | -20.3% |
Analyst sentiment has turned less bullish. Three months ago, there were five Buy ratings and one Overweight. Now, the number of positive ratings stands at four.
No UiPath corporate events are planned for the coming week. U.S. consumer price figures are set for release on Wednesday, August 12. Producer price data will be published Thursday, and retail sales numbers will be released Friday.
Stronger-than-expected inflation data may push yields higher and weigh on software stock prices, while weaker numbers could bolster demand for growth stocks. UiPath’s upcoming company update follows the September 3 close.
Risks: An unexpected ARR surge or quicker agentic-product conversions may render current analyst forecasts outdated. Conversely, a midpoint update, elevated yields, or delayed enterprise rollouts have the potential to end the rally.
The current target is the upper end of quarterly ARR guidance at $1.934 billion. Surpassing this mark would provide the rally with fundamental backing. Meeting the midpoint would position the stock above analyst estimates but short of the first-quarter ARR growth rate.
Related articles: NYSE:PATH
